Search Results
Perspectives
Making a difference with meaningful innovation for our patients, healthcare providers and in our communities
Baxter Ventures
Created in 2011 by Baxter International Inc., Baxter Ventures builds on the company’s more than 85-year legacy of supporting healthcare innovation and saving and sustaining lives worldwide.
Our Story
Baxter touches the lives of millions of people around the world every day. Our products and therapies can be found throughout hospitals and clinics – from the ER to the OR, from the pharmacy to the ICU – as well as advancing patients’ care in their homes.
Fueling Collaborative Innovation
To continue to transform and increase access to care for patients around the world, we are investing in new collaborations, partnering with world-renowned institutions, seeking out the next-generation of innovators in healthcare and funding the pursuit of new discoveries and research.
Partners and Suppliers
Partnering with Baxter to provide life-saving and -sustaining products and therapies globally.
Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027
Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes.
Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027
Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the early tender results for the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The tender offers are being made pursuant to the terms and conditions set forth in the offer to purchase, dated Nov. 19, 2025, as amended by the Company’s press release dated Nov.
Baxter Announces Tender Offers for 2026 Notes and 2027 Notes
Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the commencement of tender offers, subject to the terms and conditions described below, to purchase for cash the debt securities issued by Baxter listed in the table below (collectively, the "Securities" and each a "series").